Heska Corporation Elects Robert L. Antin to Board of Directors

Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty products, appointed Robert L. Antin, the Founder of VCA Antech, Inc., to the Company’s Board of Directors, effective Nov. 17, 2020.

Mr. Antin was a founder of VCA Antech, Inc. (“VCA”), a publicly traded national animal healthcare company that provides veterinary services, diagnostic testing and various medical technology products and related services to the veterinary market. Mr. Antin has served as a Director, Chief Executive Officer and President at VCA since its inception in 1986. From September 1983 to 1985, Mr. Antin was President, Chief Executive Officer, a Director and co-founder of AlternaCare Corp., a publicly held company that owned, operated and developed freestanding out-patient surgical centers. From July 1978 until September 1983, Mr. Antin was an officer of American Medical International, Inc., an owner and operator of health care facilities. Mr. Antin received his Bachelor’s degree from the State University of New York at Cortland and his MBA with a certification in hospital and health administration from Cornell University.

“I have known and admired Bob for more than 20 years,” said Kevin Wilson, the Company’s Chief Executive Officer and President. “I can think of nobody more central and impactful to the growth of pet healthcare than Bob Antin. Bob is the key figure in launching much of our industry, having manifested the vision, liquidity, scale and execution to build the veterinary hospital, specialty hospital and central reference laboratory businesses that today lead and largely define a great deal of our industry. As Heska continues to grow rapidly and to solidify its central role in the global pet healthcare industry, we are made much stronger with Bob’s addition to our team.”

“The admiration is mutual,” commented Mr. Antin. “I have long respected Heska. The Company’s uncanny ability to grow in such a competitive market is unique and compelling. I look forward to working closely with Heska management and the Company’s strong team of Directors to continue this trend and forge new inroads for the betterment of Heska’s shareholders and the veterinary health landscape.”